Summary
Investigations in Bengaluru and Delhi have revealed the distribution of counterfeit medications, including diverted cancer treatments, in various hospitals, highlighting vulnerabilities in the pharmaceutical supply chain. Robust technology and verification processes are needed to combat these fake-drug rackets.